HARTFORD, CT – Governor Ned Lamont of Connecticut, Governor Andrew M. Cuomo of New York, and Governor Phil Murphy of New Jersey today announced a joint incoming travel advisory that all individuals traveling from states with significant community spread of COVID-19 self-quarantine for a 14-day period from the time of last contact within the identified state.
This self-quarantine – effective 11:59 p.m. on Wednesday, June 24, 2020 – applies to any person arriving from a state with a positive test rate higher than 10 per 100,000 residents or a state with a 10 percent or higher positivity rate over a 7-day rolling average.
Connecticut, New York, and New Jersey will continually update and publish on their respective websites a list of states to which the new advisory applies. This information will be updated regularly.
The tri-state measure will use uniform parameters and messaging on highways, airports, websites and social media across the three states. The three states will also ask hotels to communicate the 14-day quarantine to guests who have traveled from one of the impacted states.
“Working together as a region has proven to be immensely successful as our respective states are leading the country when it comes to our response with low infection and positivity rates relative to increased testing capacity,” Governor Lamont said. “We have made difficult decisions throughout this pandemic, but we have proven to make many of the right decisions. This step to inform travelers form states with hot spots to self-isolate is meant to protect our residents and maintain our incredible public health progress.”
“In New York, we went from the highest number of cases to some of the lowest rates in the country – no one else had to bend the curve as much as we did and now we have to make sure that the rate continues to drop in our entire region,” Governor Cuomo said. “We’ve been working with our neighbors in New Jersey and Connecticut throughout this entire pandemic, and we’re announcing a joint travel advisory that says people coming in from states with a high infection rate must quarantine for 14 days. We’ve worked very hard to get the viral transmission rate down and we don’t want to see it go up again because people are traveling into the state and bringing it with them.”
“Over the course of the past few months, our states have taken aggressive action to flatten the curve and beat back the coronavirus,” Governor Murphy said. “As a result of our collective efforts, we have low infection rates, falling hospitalizations, and have steadily been reopening our economies. Unfortunately, many states continue to have high transmission rates. We are proud to work with our partners in New York and Connecticut on a joint incoming travel advisory to ensure continued progress against this virus and to keep residents of the tri-state area safe.”
This press release is made possible by:
Visit BMW of Bridgeport at: https://www.bmwofbridgeport.com/
WASHINGTON—U.S. Senators Chris Murphy (D-Conn.), John Cornyn (R-Texas), Richard Blumenthal (D-Conn.),and Martha McSally (R-Ariz.) urged Senate appropriators to include at least an additional $25 million for the Department of Justice to hire additional National Instant Criminal Background Checks (NICS) staff. In a letter
to U.S. Senate Appropriations Subcommittee on Commerce, Justice, Science, and Related Agencies Chairman Jerry Moran and Ranking Member Jeanne Shaheen, the senators noted the increase in guns and ammunition sales since the COVID-19 pandemic, highlighting the urgency to hire additional NICS examiners so background checks can be completed accurately and in a timely manner.
“The NICS system is the cornerstone of our legal transfer firearms process in the United States, helps to protect the Second Amendment rights of law-abiding citizens, and helps to ensure that prohibited individuals cannot purchase a firearm from a licensed dealer,” the senators wrote.
The senators continued: “Even before COVID-19, the number of background checks run through the NICS system was increasing, resulting in backlogs. Then, as Americans began to grapple with COVID-19 at the beginning of this year, gun and ammunition sales skyrocketed throughout the country. In March, FBI conducted over 3.7 million background checks, a new record. Five of its 10 busiest weeks ever have occurred in early 2020 during this pandemic.”
“Given that sales have increased substantially compared to March, April, and May 2019, additional NICS examiners are critical in ensuring the timely and accurate completion of background checks. I therefore request that any future COVID-19 package include at least an additional $25 million to hire additional NICS staff,” the senators concluded.
WETHERSFIELD, CT – The Connecticut Department of Motor Vehicles will reopen select offices on June 23, 2020. Services will be offered by appointment only. Details are below:
Road Tests (Non-CDL)
Road testing will resume June 23, 2020. Approximately 1,000 road tests have been rescheduled
through June 30th
.
Customers are being called by DMV staff to schedule previously canceled appointments.
Services Offered by Appointment at the DMV
Appointments are now available for new licenses and IDs, license and ID renewals, out of state license and registration transfers, and CDL upgrades.
Locations for Learner’s Permit Knowledge Tests: Wethersfield, Cheshire, Willimantic, Old Saybrook, Norwalk, and Danbury.
Registration Services (new registrations) will begin on June 30, 2020 at these locations:
Wethersfield, Willimantic, and Danbury
o Appointments can be made by visiting: https://portal.ct.gov/dmv/
o Link located within the “yellow alert box” to the appointment page.
This press release was made possible by:
Visit BMW of Bridgeport at: https://www.bmwofbridgeport.com/
HARTFORD, CT) – Governor Ned Lamont today announced his support for the Volunteer Income Tax Assistance (VITA) Program and its statewide expansion. The program provides free help for Connecticut’s low-income and ALICE families to file tax returns, allowing them to receive tax credits and Coronavirus economic impact checks and to file for Pandemic Unemployment Assistance (PUA) benefits. All residents making up to $56,000 in income are eligible for the services. Administered by the Connecticut Association for Human Services (CAHS), the virtual VITA program is the first IRS-approved end-to-end digital portal to carry out these services, allowing it to rapidly scale operations statewide.
Residents can access the full Virtual VITA services online at www.cahs.org/covid_relief. Residents can also dial 2-1-1 to find the nearest in-person VITA service site or the nearest virtual VITA portal, which offers computers for residents to log on and submit their claims. VITA works with municipalities and local community groups to provide service and accommodate residents across the state.
Economic impact payments available through the Coronavirus Aid, Relief, and Economic Security (CARES) Act of up to $1,200 for individuals or $2,400 for married couples, and up to $500 for each qualifying child are only available to those who have filed a 2018 or 2019 tax return, so virtual VITA opens the door for residents who don’t normally file a tax return to receive sorely needed financial support.
Since the start of the COVID-19 crisis, beneficiaries of VITA’s tax filing service have received an average of approximately $3,000 from stimulus checks and tax credits such as the Earned Income Tax Credit and the Child Tax Credit from filing their tax returns. Those whom VITA has also helped file for unemployment benefits will receive average additional benefits of approximately $20,000 during the year. In total, VITA has delivered approximately $30 million this past year in funds received for its beneficiaries in Connecticut.
“Many Connecticut families deeply affected by the COVID-19 crisis are unfortunately not receiving the financial support they are entitled to by the CARES stimulus, Pandemic Unemployment Assistance, or other government programs,” Governor Lamont said. “I applaud the work that VITA is doing to get our citizens the financial help they need and deserve, and our state is are committed to supporting the efforts of this important organization to connect with and assist eligible Connecticut residents.”
CAHS has been supported in its expansion by the philanthropic organization 4-CT, which was created with the express purpose of providing emergency assistance to the state’s residents during the current pandemic.
“VITA and CAHS have proven to be an incredibly dynamic partner in pandemic support efforts,” Ted Yang, CEO of 4-CT, said. “Few solutions empower individuals more in accelerating the pace of the government’s response to layoffs and loss of income that we’ve been seeing across the country. 4-CT will continue to work helping the state get through the COVID-19 crisis as securely as possible.”
“We appreciate the support that Governor Lamont’s administration and 4-CT have provided and are proud to offer this critical service to families in our community at a time when they need our support the most,” John Merz, CEO of CAHS, said. “We look forward to continuing to serve the population of Connecticut and getting financial resources to those that need it the most as quickly as possible.”
Connecticut residents who have not filed a 2019 tax return or who have become unemployed but have not yet filed for Pandemic Unemployment Assistance should visit the CAHS website to learn if they are eligible and register for VITA’s free assistance. VITA also recently announced a Referral Incentive Program, whereby philanthropic organizations within Connecticut can receive cash bonuses for referring eligible VITA beneficiaries who successfully complete the program.
VITA estimates that as many as 140,000 people across the State of Connecticut may be eligible for some type of cash benefit from the government. The deadline for filing tax returns has been extended to July 15, 2020, and the deadline for applying for CARES stimulus funds is October 15, 2020.
HARTFORD, CT) – Governor Ned Lamont released the following statement regarding the package of legislative proposals announced today by the Senate Democratic caucus:
“I plan on calling the General Assembly into special session during the month of July to address the issues of police accountability and expanding access to absentee ballots. There’s still more that we need to do in addition to those issues to address the complex and difficult problems of racial and economic inequality. I look forward to working with legislators and other stakeholders on those issues during the next regular session.”
WASHINGTON, D.C.] – U.S. Senator Richard Blumenthal (D-CT) and U.S. Representatives Gerald E. Connolly (D-VA) and Francis Rooney (R-FL) led the introduction of a resolution denouncing discriminatory treatment of Iranian Americans. This bicameral, bipartisan resolution comes after earlier this year, a U.S. Customs and Border Protection (CBP) office on the U.S.-Canada border was found to have directed its agents to detain and question Americans of Iranian origin about their faith and military service following the U.S. killing of Iranian general Qassem Soleimani. The resolution calls on the U.S. Department of Homeland Security to launch a civil rights probe into the incident and directs government officials to ensure that civil rights and liberties of all Americans – including Iranian Americans – are protected.
“The prejudice Iranian Americans experienced at the hands of federal border officials earlier this year will simply not be tolerated in our country,” said Blumenthal. “I am proud to co-sponsor this important resolution with congressional colleagues from both sides of the aisle to completely denounce such acts of bigotry and take steps to ensure this never happens again. The Department of Homeland Security must launch a full and complete investigation into this shameful incident, and leaders across the country must reaffirm our nation’s commitment to protect the civil rights and liberties of all Americans – including Iranian Americans.”
“Earlier this year, dozens of Americans of Iranian heritage were detained at the border at the direction of Customs and Border Protection agents,” said Connolly. “There is no place for such bigotry or acts of discrimination against any American. This resolution unequivocally condemns such discriminatory treatment, urges the Department of Homeland Security to conduct a civil rights investigation into this matter, and calls upon government leaders and law enforcement personnel to ensure that the civil rights and civil liberties of all Americans, including Iranian Americans, are fully protected.”
“Iranian Americans are being profiled by U.S. Customs and Border Protection (CBP) for no reason other than appearance,” said Rooney. “This is illegal and unacceptable. This is why Congressman Gerald Connolly and I introduced a bipartisan resolution to acknowledge the diversity of the Iranian American community and their contributions to the socioeconomic fabric of America. Many Iranian Americans serve in our military, contribute to our small and large businesses, hold elected government positions, and work in our law enforcement. This resolution sheds light on the importance of maintaining and promoting the civil rights and liberties that the Iranian American community deserves.”
The resolution was co-sponsored by U.S. Senator Tim Kaine (D-VA) in the Senate and U.S. Representatives Scott Peters (D-CA) and Michael Waltz (R-FL) in the House.
“Iranian-Americans have made immense contributions across American society,” said Kaine. “I’m proud that many of them call Virginia home. And I’m glad to join this group of bicameral, bipartisan colleagues to condemn discrimination against the Iranian-American community at the hands of federal border officials earlier this year. Congress must stand strong against discrimination in all its forms.”
The resolution was also endorsed by the Public Affairs Alliance of Iranian Americans (PAAIA).
“I applaud congressional leaders for their efforts to encourage local, state and federal elected officials to engage with Iranian Americans to end harmful stereotypes and protect our community’s civil liberties and civil rights,” said PAAIA Executive Director Leila Austin. “The discrimination of anyone based on ethnicity or national origin does not speak to the values of our great nation. I am hopeful that through the introduction of these resolutions, efforts will be made to eradicate this discrimination from our communities and in government. I thank Sen. Blumenthal and Reps. Connolly and Rooney as well as the resolutions’ bi-partisan co-sponsors Sen. Kaine and Reps. Peters and Waltz for shining a spotlight on this issue and for putting forth recommendations to discourage the discrimination of any American based on their race, color, religion, national origin or ethnicity.”
This press release was made possible by:
Visit BMW of Bridgeport at: https://www.bmwofbridgeport.com/
WASHINGTON—U.S. Senator Chris Murphy (D-Conn.) on Wednesday applauded Senate passage of the Great American Outdoors Act. The bipartisan legislation, which passed by a vote of 73-25, fully and permanently funds the Land and Water Conservation Fund (LWCF) at $900 million per year. The LWCF is the main federal program to ensure protection of and access to our public lands. The Great American Outdoors Act will also address our nearly $12 billion repair backlog in National Parks and on other public lands by directing up to $9.5 billion over five years to address maintenance needs within the National Park System. The legislation now heads to the U.S. House of Representatives, and President Trump has signaled he would sign this bill into law.
“Today is big win for our public lands. The Great American Outdoors Act fully funds the Land and Water Conservation fund which is critical to preserving Connecticut’s public parks, restoring our aging park facilities and infrastructure, and creating good jobs. This bill also funds much needed outdoor infrastructure programs in urban communities in our state, so everyone can access the outdoors. Good things happen when Congress puts politics aside, and this bill is evidence of that,” said Murphy.
LWCF is a critical tool to protect iconic landscapes, recreation areas, wetlands, and wildlife refuges in Connecticut and has funded over $60 million in conservation projects across the state since the program was created in 1965. As the threats from climate change become more severe, providing permanent funding for LWCF will help Connecticut mitigate and adapt to those shifts. In addition, with aging park facilities and decreased visitation revenue, this bill will help address the deferred maintenance backlog of $2.3 million at Connecticut’s National Park sites.
#WASHINGTON, D.C. – U.S. Senator Richard Blumenthal (D-CT), author of the Restoring Aviation Accountability Act and a member of the Senate Committee on Commerce, Science & Transportation, released the following statement on the Aircraft Safety and Certification Reform Act, introduced earlier today by U.S. Senators Roger Wicker (R-MI) and Maria Cantwell (D-WA), the Chair and Ranking Member of the Commerce Committee.
“I’m glad to see this bipartisan reform proposal include several provisions I’ve championed, including stronger protections for whistleblowers, minimum qualifications for those preforming work on behalf of the FAA, targeted audits of ODA units, and addressing concerns about compensation and bonuses for meeting performance goals,” Blumenthal said. “Left to its own devices, the aviation certification system puts corporate profits before consumer safety. I look forward to working with my Commerce Committee colleagues to make this legislation even stronger – returning power to federal regulators, restoring accountability, and reforming industry oversight.”
Earlier this year, Blumenthal and U.S. Senators Edward J. Markey (D-MA), Tom Udall (D-NM), Elizabeth Warren (D-MA), and Dianne Feinstein (D-CA) introduced comprehensive legislation revamping oversight of the aviation industry to prioritize consumer safety. The Restoring Aviation Accountability Act effectively reverses the provisions enacted by the Federal Aviation Administration (FAA) Reauthorization Act of 2018, which allowed the aviation industry to regulate many of its own certification processes. As a result, Boeing’s automated system MCAS, which has been widely recognized as the cause of the deadly Boeing 737 MAX 8 crashes, was never fully analyzed by the FAA while Boeing downplayed its risks.
Among a number of reforms, the Restoring Aviation Accountability Act would:
· Establish a commission to review the current FAA safety delegation program (ODA) to determine and evaluate if alternative certification programs would provide more robust oversight.
· Increase the accountability measures of the current safety oversight system by requiring that pay, compensation, and bonuses for officers and employees of the FAA are not contingent on the delivery of airplanes, the number of aircraft certified, or the number of audits completed. Prohibits safety certification system employees of manufacturers from having performance standards tied to delivery of aircraft.
· Require a comprehensive, independent audit of ODA practices, safety management, and the organization management team responsible for overseeing the ODA holder at least once every three years, regardless of the length of time that the entity has been an authorized ODA holder.
· Establish an independent panel to review each aircraft type certificate every five years, as well any amendment to an existing type certificate, and make recommendations about whether the application for a new type certificate is warranted. This provision would also require the Administrator to review the panel’s recommendations to determine whether the aircraft is airworthy or if the manufacturer needs to apply for a new type certificate.
· Bolster whistleblower incentives and protections in the aviation industry for employees, contractors, and subcontractors of aircraft manufacturers, aircraft repair stations, and the FAA by providing whistleblowers with access to court for a jury trial and monetary incentives for information that leads to a successful resolution of a complaint.
This press release was made possible by:
Visit BMW of Bridgeport at: https://www.bmwofbridgeport.com/
The Connecticut Police Chiefs Association, which represents over 100 Municipal and University Police Chiefs that lead 0ver 8500 municipal police officers in our state, have agreed to a 90-day moratorium on the acquisition of surplus military equipment.
Hartford, CT) – Attorney General William Tong led a coalition of 51 states and territories today in filing the third lawsuit stemming from the ongoing antitrust investigation into a widespread conspiracy by generic drug manufacturers to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade for generic drugs sold across the United States. This new Complaint, filed in the U.S. District Court for the District of Connecticut, focuses on 80 topical generic drugs that account for billions of dollars of sales in the United States. The Complaint names 26 corporate Defendants and 10 individual Defendants. The lawsuit seeks damages, civil penalties, and actions by the court to restore competition to the generic drug market.
The topical drugs at the center of the Complaint include creams, gels, lotions, ointments, shampoos, and solutions used to treat a variety of skin conditions, pain, and allergies.
“These generic drug manufacturers perpetrated a multibillion-dollar fraud on the American public so systemic that it has touched nearly every single consumer of topical products. Through phone calls, text messages, emails, corporate conventions, and cozy dinner parties, generic pharmaceutical executives were in constant communication, colluding to fix prices and restrain competition as though it were a standard course of business. But they knew what they were doing was wrong, and they took steps to evade accountability, using code words and warning each other to avoid email and detection. Our case is built on hard evidence from multiple cooperating witnesses, millions of records, and contemporaneous notes that paint an undeniable picture of the largest domestic corporate cartel in our nation’s history. Our investigation is ongoing and expanding, and we will not rest until competition is restored and those responsible are held fully accountable,” said Attorney General Tong.
The Complaint stems from an ongoing investigation built on evidence from several cooperating witnesses at the core of the conspiracy, a massive document database of over 20 million documents, and a phone records database containing millions of call detail records and contact information for over 600 sales and pricing individuals in the generics industry. Among the records obtained by the States is a two-volume notebook containing the contemporaneous notes of one of the States’ cooperators that memorialized his discussions during phone calls with competitors and internal company meetings over a period of several years.
Between 2007 and 2014, three generic drug manufacturers, Taro, Perrigo, and Fougera (now Sandoz) sold nearly two-thirds of all generic topical products dispensed in the United States. The multistate investigation has uncovered comprehensive, direct evidence of unlawful agreements to minimize competition and raise prices on dozens of topical products. The Complaint alleges longstanding agreements among manufacturers to ensure a “fair share” of the market for each competitor, and to prevent “price erosion” due to competition.
The Complaint is the third to be filed in an ongoing, expanding investigation that the Connecticut Office of the Attorney General has referred to as possibly the largest domestic corporate cartel case in the history of the United States. The first Complaint, still pending in the U.S. District Court in the Eastern District of Pennsylvania, was filed in 2016 and now includes 18 corporate Defendants, two individual Defendants, and 15 generic drugs. Two former executives from Heritage Pharmaceuticals, Jeffery Glazer and Jason Malek, have entered into settlement agreements and are cooperating with the Attorneys General working group in that case. The second Complaint, also pending in the U.S. District Court in the Eastern District of Pennsylvania, was filed in 2019 against Teva Pharmaceuticals and 19 of the nation’s largest generic drug manufacturers. The Complaint names 16 individual senior executive Defendants. The States are currently preparing for trial on that Complaint.
Corporate Defendants:
Sandoz, Inc.
Actavis Holdco U.S., Inc.
Actavis Elizabeth LLC
Actavis Pharma, Inc.
Amneal Pharmaceuticals, Inc.
Amneal Pharmaceuticals, LLC
Aurobindo Pharma USA, Inc.
Bausch Health Americas, Inc.
Bausch Health, US LLC
Fougera Pharmaceuticals, Inc.
G&W Laboratories, Inc.
Glenmark Pharmaceuticals Inc., USA
Greenstone LLC
Lannett Company, Inc.
Lupin Pharmaceuticals, Inc.
Mallinckrodt Inc.
Mallinckrodt plc
Mallinckrodt LLC
Mylan Inc.
Mylan Pharmaceuticals Inc.
Perrigo New York, Inc.
Pfizer, Inc.
Sun Pharmaceutical Industries, Inc.
Taro Pharmaceuticals USA, Inc.
Teligent, Inc.
Wockhardt USA, LLC
Individual Defendants:
Ara Aprahamian, the Vice President of Sales and Marketing at Defendant Taro Pharmaceuticals U.S.A, Inc.
Mitchell Blashinsky, the Vice President of Marketing for Generics at Defendant Taro Pharmaceuticals USA, Inc. from January 2007 through May 2012, and Vice President of Sales and Marketing at Defendant Glenmark Pharmaceuticals Inc., USA from June 2012 through March 2014.
Douglas Boothe, the Chief Executive Officer of Defendant Actavis from August 2008 through December 2012 and the Executive Vice President and General Manager of Defendant Perrigo New York, Inc. from January 2013 through July 2016.
James Grauso, the former Vice President of Sales and Marketing at Defendant G&W Laboratories from January 2010 through December 2011; the Senior Vice President, Commercial Operations for Defendant Aurobindo from December 2011 through January 2014; and the Executive Vice President, N.A. Commercial Operations at Defendant Glenmark from February 2014 to the present.
Walt Kaczmarek, the Senior Director, National Accounts, Vice President, National Accounts and Senior Vice President, Commercial Operations from November 2004 through November 2012 for Fougera Pharmaceuticals, a division of Nycomed US, Inc. (currently part of Defendant Sandoz, Inc.), and Vice President – General Manager, and President, Multi-Source Pharmaceuticals from November 2013 through August 2016 for Defendant Mallinckrodt.
Armando Kellum, the former Vice President, Contracting and Business Analytics at Sandoz.
Kurt Orlofski, the President and Chief Executive Officer from April 2007 through August 2009 for Defendant Wockhardt USA, and President of Defendant G&W Labs, Inc. from September 2009 through December 2016.
Mike Perfetto, the Vice President of Sales and Marketing for Defendant Actavis from August 2003 through January 2013, and the Chief Commercial Officer for Defendant Taro from January 2013 through his recent retirement from the company.
Erika Vogel-Baylor, the former Vice President for Sales and Marketing for Defendant G&W Labs, Inc. since July 2011.
John Wesolowski, the Senior Vice President of Commercial Operations for Defendant Perrigo since February 2004.
Drugs listed in the complaint as subject to price-fixing and market allocation agreements:
Acetazolamide Tablets
Adapalene Cream
Alclometasone Dipropionate Cream
Alclometasone Dipropionate Ointment
Ammonium Lactate Cream
Ammonium Lactate Lotion
Betamethasone Dipropionate Cream
Betamethasone Dipropionate Lotion
Betamethasone Valerate Cream
Betamethasone Valerate Lotion
Betamethasone Valerate Ointment
Bromocriptine Mesylate Tablets
Calcipotriene Solution
Calcipotriene Betamethasone Dipropionate Ointment
Carbamazepine ER Tablets
Cefpodoxime Proxetil Oral Suspension
Cefpodoxime Proxetil Tablets
Ciclopirox Cream
Ciclopirox Shampoo
Ciclopirox Solution
Clindamycin Phosphate Cream
Clindamycin Phosphate Gel
Clindamycin Phosphate Lotion
Clindamycin Phosphate Solution
Clobetasol Propionate Cream
Clobetasol Propionate Emollient Cream
Clobetasol Propionate Gel
Clobetasol Propionate Ointment
Clobetasol Propionate Solution
Clotrimazole 1% Cream
Clotrimazole Betamethasone Dipropionate Cream
Clotrimazole Betamethasone Dipropionate Lotion
Desonide Cream
Desonide Lotion
Desonide Ointment
Desoximetasone Ointment
Econazole Nitrate Cream
Eplerenone Tablets
Erythromycin Base/Ethyl Alcohol Solution
Ethambutol HCL Tablets
Fluocinolone Acetonide Cream
Fluocinolone Acetonide Ointment
Fluocinonide .1% Cream
Fluocinonide Gel
Fluocinonide Ointment
Fluocinonide Solution
Fluticasone Propionate Lotion
Griseofulvin Microsize Tablets
Halobetasol Propionate Cream
Halobetasol Propionate Ointment
Hydrocortisone Acetate Suppositories
Hydrocortisone Valerate Cream
Imiquimod Cream
Ketoconazole Cream
Latanoprost Drops
Lidocaine Ointment
Methazolamide Tablets
Methylphenidate HCL Tablets
Methylphenidate HCL ER Tablets
Metronidazole Cream
Metronidazole .75% Gel
Metronidazole .1% Gel
Metronidazole Lotion
Mometasone Furoate Cream
Mometasone Furoate Ointment
Mometasone Furoate Solution
Nafcillin Sodium Injectable Vials
Nystatin Ointment
Nystatin Triamcinolone Cream
Nystatin Triamcinolone Ointment
Oxacillin Sodium Injectable Vials
Phenytoin Sodium ER Capsules
Pioglitazone HCL Metformin HCL Tablets
Prochlorperazine Maleate Suppositories
Promethazine HCL Suppositories
Tacrolimus Ointment
Terconazole Cream
Triamcinolone Acetonide Cream
Triamcinolone Acetonide Ointment
Triamcinolone Acetonide Paste
Attorney General Tong led the attorneys general of Alabama, Alaska, Arizona, Arkansas, Colorado, Delaware, District of Columbia, Florida, Georgia, Territory of Guam, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Northern Mariana Islands, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, Tennessee, Utah, U.S. Virgin Islands, Vermont, Virginia, Washington, West Virginia and Wisconsin in filing the complaint.
Assistant Attorneys General Joseph Nielsen, Laura Martella, Antonia Conti, Rachel Davis, and Christine Miller; Paralegal Gaile Colaresi; and Assistant Attorney General Michael Cole, chief of the Antitrust and Government Program Fraud Department, are assisting the Attorney General with this matter.
